Author:Rolando L. deGoma, MDCapital Cardiology Associates
Citation:deGoma RL. Coronary calcium scan: the role of calcium scoring in preventing a first myocardial infarction [published online September 25, 2019]. Cardiology Consultant.
About 720,000 new coronary events and 335,000 recurrent coronary events occur each year, according to data from the American Heart Association.1 How many of the 720,000 first coronary events can be prevented? Most of them. First, we need to identify high-risk patients, and then quickly treat the patients to prevent plaque rupture, stop plaque progression, and induce plaque regression.
IDENTIFYING HIGH-RISK PATIENTS
The Framingham Risk Score2 is the most common method for calculating patients 10-year risk for coronary heart disease (CHD). It is very inaccurate, though, resulting in undertreatment, overtreatment, and even nontreatment if the patient or care provider is nonadherent. Patients with a Framingham Risk Score of more than 20% are at high risk for cardiovascular disease (CVD) events, but the approach does not answer two fundamental questions: (1) does the patient have or not have plaque, and (2) how much plaque is present?
This approach is like reading the patients palm to determine the likelihood of having a myocardial infarction, stroke, or sudden vascular death based on ones age, sex, blood pressure, high-density lipoprotein cholesterol (HDL-C), smoking status, and other risk factors. In the last 10 years, coronary calcium scoring has become more accessible and affordable, at $39 to $400 for the test, and most patients are willing to pay out-of-pocket if they understand what the test is for.
Calcium scoring is like mammography for the heart but only needs to be performed once for most patients. It is not an annual test and requires no special preparation, no fasting, no intravenous line, no injection, no exercise, and very low radiation exposure. Moreover, the test is usually completed in less than 30 seconds. The results show the presence or absence of calcified plaquesan accurate reflection of total plaque burden. The score can range from 0 to more than 4000. Someone with a score between 100 and 300 has moderate plaque deposits and a high risk for myocardial infarction in the next 3 to 5 years.3 The need for and the intensity of medical therapy are determined accordingly.
Some patients may ask about undergoing a nuclear stress test instead. Hospital charges for a nuclear stress test are around $30,000! About 68% of plaques that rupture only obstruct the artery by 50% or less and therefore do not cause an abnormal stress test. Stress testing plays no role in the risk assessment of asymptomatic patients. Normal results from a nuclear stress test do not mean that the patient is not at high risk or that the patient is at low risk. A patient can have a calcium score of more than 2000 and still have normal stress test results.
PREVENTING CVD EVENTS
My journey to myocardial infarction (and stroke) prevention started in 2001 when I realized that the future of CVD management will not require implanting more stents and performing more heart bypass procedures. A nationwide physician survey4 had revealed that only 18% of patients with CHD were successful in achieving a low-density lipoprotein cholesterol (LDL-C) level of less than 100 mg/dL; 82% were either not being treated with a statin or were not treated adequately.4
I decided to find a way to incorporate aggressive prevention as part of every patient visit. This led to my creation and development of a numerically goal-oriented clinical management system that includes CVD risk assessment for every patient and setting treatment goals based on the magnitude of risk. The higher the risk, the lower the LDL-C treatment goal. I called this approach the PaKS-ACCEPT system.5
We published our first analysis of LDL-C treatment performance data6 in 2006 and the second analysis5 in 2017. In 2006, 85% of high-risk patients (CHD and CHD risk-equivalent patients) were successfully treated to an LDL-C level of less than 100 mg/dL using our PaKS-ACCEPT system, and 32% had an LDL-C level below 70 mg/dL.6
In 2017, 89% of patients had reached LDL-C levels of less than 100 mg/dL, and 52% were below 70 mg/dL.5 CVD events declined progressively every year to the point that they had become uncommon. The duration of treatment is directly proportional to the magnitude of event reduction. Therefore, if we are able to identify the patients who may experience a first myocardial infarction before it happens, we can accurately prevent these debilitating events.
There are many practical implications of knowing the coronary calcium score for the primary prevention of CHD and CVD events. For one, patients are more likely to accept and take appropriate medical therapy. For example, a 50-year-old man and a 60-year-old woman had calcium scores of 850 and 450, respectively. They were both started on statin therapy, and their on-treatment LDL-C levels were both less than 70 mg/dL. They would not have been prescribed a statin if they did not have their calcium score.
Another of my patients needed to be on statin therapy but had refused for years. Once he found out that his calcium score was 500, he started taking a statin.
Conversely, another of my patients had been on several different statins but continued to experience intermittent muscle aches. We conducted a calcium score scan and found that her calcium score was 0. The statins were discontinued, and her myalgia resolved after several weeks.
Another of my patients was taking low-dose statin but was not achieving her LDL-C goal. She refused to take a higher-dose statin in combination with ezetimibe. However, after finding her calcium score was 1200, the patient agreed to take statin-ezetimibe combination therapy. Her on-treatment LDL-C level dropped to 45 mg/dL.
ENDING THE WAR ON HEART DISEASE
For decades, the American Heart Association and the American College of Cardiology have been actively waging a war to end heart disease. In 2016, the American College of Cardiologys president, Kim Allan Williams, MD, said, We must turn off the faucet instead of just mopping the floor.7 He meant that we, as cardiologists, need to prevent cardiac events before they start, effectively ending the war on heart disease. Coronary calcium scoring provides the new tool that we need to continue our fight and stop myocardial infarctions before they happen.
Rolando L. deGoma, MD, FACC, FNLA, is a cardiologist at Capital Cardiology Associates in Trenton, New Jersey.
See the original post:
- Effect of Ciclosporin on Safety, Lymphocyte Kinetics and Left Ventricular Remodelling in Acute Myocardial Infarction - DocWire News - February 20th, 2020
- Stem cells and the heartthe road ahead - Science Magazine - February 20th, 2020
- Revascularization Volumes Halved Over 13 Years - Medscape - February 20th, 2020
- The Foundation of Performance Improvement - ModernHealthcare.com - February 20th, 2020
- Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction: A Nationwide Study - DocWire News - February 20th, 2020
- Abiomed: Straight From The Heart - Seeking Alpha - February 20th, 2020
- Global Myocardial Infarction Treatment Market Set to reach USD 1726.3 Million by end of 2022 - Global Newspaper 24 - February 20th, 2020
- Predicting the One-Year Prognosis and Mortality of Patients with Acute | CIA - Dove Medical Press - February 20th, 2020
- Sex-Specific Trends in Acute Myocardial Infarction Within an Integrated Healthcare Network, 2000 Through 2014 - DocWire News - February 19th, 2020
- Exposure to Air Pollution Particles Linked with Non-fatal Heart Attacks: Study - DocWire News - February 19th, 2020
- February is Heart Month: The seriousness of chest pain | The - Waukon Standard - February 19th, 2020
- American Heart Association Journal Finally Retracts Study Implying That E-Cigarettes Cause Heart Attacks Before People Use Them - Reason - February 19th, 2020
- Inpatient Mortality and 30-Day Readmission Rates Associated with Troponin Testing in Patients without Acute Myocardial Infarction - DocWire News - February 19th, 2020
- Myocarditis Presenting as Typical Acute Myocardial Infarction: A case Report and Review of the Literature - DocWire News - February 19th, 2020
- Identification of Factors Associated With Contrast-Induced Nephropathy After PCI - The Cardiology Advisor - February 19th, 2020
- Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study - DocWire News - February 19th, 2020
- Tiny bits of air pollution may trigger nonfatal heart attacks - Futurity: Research News - February 19th, 2020
- Recardio announces conclusion of interim analysis of Phase 2 in AMI - News.MarketSizeForecasters.com - February 19th, 2020
- Myocardial Infarction: Exposure to Air Pollutants Can Lead to This Debilitating Condition - India.com - February 19th, 2020
- Migraine Headache and Risk for Cardiovascular and Cerebrovascular Events - The Cardiology Advisor - February 19th, 2020
- Tissue Plasminogen Activator Market: Overview with Detailed Analysis, Competitive Landscape Forecast to 2027 - Press Release - Digital Journal - February 19th, 2020
- Survivors in Canada are Taking Steps to Reduce the Risk of Another Heart Attack. But is it Enough? - Yahoo Finance - February 6th, 2020
- Effect of Low-Dose Nebivolol in Patients with Acute Myocardial Infarction: A Multi-Center Observational Study - DocWire News - February 6th, 2020
- Global Myocardial Infarction Treatment Market to garner returns to garner returns worth USD 1726.3 Million by end of 2022 - Global Newspaper 24 - February 6th, 2020
- Evaluating the Impact of Diabetes on the Performance of Algorithms for the Detection of AMI Without ST-Elevation - The Cardiology Advisor - February 5th, 2020
- Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program... - February 5th, 2020
- Aortic Stiffness and Infarct Healing in Survivors of Acute ST-Segment-Elevation Myocardial Infarction - DocWire News - February 5th, 2020
- Apabetalone Receives Breakthrough Therapy Designation for MACE Prevention - Endocrinology Advisor - February 5th, 2020
- What is a silent heart attack? How to recognize the warning signs - Insider - INSIDER - February 5th, 2020
- Apabetalone Gets Breakthrough Tx Designation for MACE Prevention - Monthly Prescribing Reference - February 5th, 2020
- Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD - | COPD - Dove Medical Press - February 5th, 2020
- Myocardial Infarction: Causes, risk factors, symptoms ... - December 19th, 2019
- Association of Prevalence of Active Transport to Work and Incidence of Myocardial Infarction: A Nationwide Ecological Study - DocWire News - December 19th, 2019
- Mandrola's Top 10 Cardiology Stories of 2019 - Medscape - December 19th, 2019
- No Causal Effects of Plasma Homocysteine Levels on the Risk of Coronary Heart Disease or Acute Myocardial Infarction: A Mendelian Randomization Study... - December 19th, 2019
- Icosapent Ethyl Approved to Reduce Risk for CV Events in High-Risk Patients - Endocrinology Advisor - December 19th, 2019
- Myocardial Infarction Treatment Market to Witness Comprehensive Growth By 2024 - Industry News Ledger - December 19th, 2019
- Survival Benefit of Coronary Revascularization after Myocardial Perfusion SPECT: The Role of Ischemia - DocWire News - December 19th, 2019
- Vascepa Approved to Cut Risk of CV Events in High-Risk Patients With Elevated Triglycerides - Monthly Prescribing Reference - December 19th, 2019
- Cardiometabolic disease costs associated with suboptimal diet in the United States: A cost analysis based on a microsimulation model. - DocWire News - December 19th, 2019
- Biden is a healthy, vigorous, 77-year-old, according to his doctor - POLITICO - December 19th, 2019
- Walking and cycling to work linked with fewer heart attacks - University of Leeds - December 19th, 2019
- Long-term ticagrelor for Secondary Prevention in Patients with Prior Myocardial Infarction and no History of Coronary Stenting: Insights From... - December 9th, 2019
- Study: Adding Aspirin to DOAC? Better Have a Good Reason - MedPage Today - December 9th, 2019
- Takeda Demonstrates Its Long-Standing Commitment to Advancing Treatments for Rare Bleeding Disorders with Studies Highlighting Real-World Evidence and... - December 9th, 2019
- Did Juice WRLD Have a Heart Attack? He Had Cardiac Arrest - Heavy.com - December 9th, 2019
- Global Myocardial Infarction Instrument Report By Industry Development, Trends, Investigation 2019 and Forecast To 2024 - The Charterian - December 9th, 2019
- Edmondson: Diabetes awareness important to future health - The Cross Timbers Gazette - December 9th, 2019
- Impact of Severe OSA on Pharmacoinvasive Treatment in ST Elevation Myocardial Infarction Patients - DocWire News - December 6th, 2019
- Arctigenin Alleviates Myocardial Infarction Injury Through Inhibition of the NFAT5-Related Inflammatory Phenotype of Cardiac Macrophages/Monocytes in... - December 6th, 2019
- The Dissimilarity Between Myocardial Infarction Patients' and Spouses' Illness Perception and its Relation to Patients' Lifestyle - DocWire News - December 6th, 2019
- Rationale and Design of the Henan ST Elevation Myocardial Infarction (STEMI) Registry: A Regional STEMI Project in Predominantly Rural Central China -... - December 6th, 2019
- Causes of Death in Patients with Acute and Chronic Myocardial Injury - DocWire News - December 6th, 2019
- Statin Adherence and Mortality in Octogenarians - Physician's Weekly - December 6th, 2019
- Complete Revascularization Beneficial in STEMI and Multivessel Disease - The Cardiology Advisor - December 6th, 2019
- The Additional Prognostic Value of Myocardial Perfusion SPECT in Patients with Known Coronary Artery Disease with High Exercise Capacity - DocWire... - December 6th, 2019
- Acute ST Elevation Myocardial Infarction Due to Allergic Reaction, Kounis Syndrome: A Case Report and Review of the Emergency Management - DocWire... - December 6th, 2019
- Heat-Shock Protein 27 (HSPB1) Is Upregulated and Phosphorylated in Human Platelets during ST-Elevation Myocardial Infarction - DocWire News - December 6th, 2019
- Post-Myocardial Infarction Market Set to Surpass US$XX Million by the end of 2018-2028 - Weekly Spy - December 6th, 2019
- Myocardial Infarction Therapeutics Market To Grow At A CAGR Of XX% Over The Forecast Period 2016 - 2026 - Weekly Spy - December 6th, 2019
- Doubts Raised on Benefits of Angioplasty and Bypass Surgery - HospiMedica - December 6th, 2019
- Myocardial Infarction Drug Market Insights, Developments, Research, Varieties, Packages, key avid gamers, Market shares and Forecast 2019 to 2023 -... - December 6th, 2019
- Amarin's Vascepa MAA for Heart Risk Indication Accepted in EU - Yahoo Finance - December 6th, 2019
- Cliff Notes to 5 Studies about the State of Cybersecurity in Healthcare - Security Boulevard - December 6th, 2019
- Peripartum myocardial infarction associated with coronary spasm and acquired protein S deficiency: A case report - DocWire News - November 30th, 2019
- Global Intravascular Temperature Management System Market, Forecast to 2027 - Acute Myocardial Infarction (AMI) is the Largest Revenue Generating... - November 30th, 2019
- Myocardial Infarction (MI), A growing concern - APN News - November 30th, 2019
- The Effect of Education and Telephone Follow-Up Intervention Based on the Roy Adaptation Model After Myocardial Infarction: Randomized Controlled... - November 30th, 2019
- Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention - 2 Minute Medicine - November 30th, 2019
- Activation of the Immune System Underlies Cardiac Cell Therapies - The Scientist - November 30th, 2019
- Global Myocardial Infarction Therapeutics Market Growth Analysis, Forecasts to 2025: Novartis NV, Daiichi Sankyo Company Limited, Bristol-Myers Squibb... - November 30th, 2019
- VEITHsymposium: Favorable Outcomes with TCAR vs Carotid Endarterectomy in Patients with Carotid Artery Disease - Cath Lab Digest - November 30th, 2019
- Alex Nowbar's weekly review29 November 2019 - The BMJ - The BMJ - November 30th, 2019
- The Next 'Big Thing' for Blood Cancers Featured at ASH 2019 - Medscape - November 30th, 2019
- Inhibition of microRNA-146a Attenuated heart Failure in Myocardial Infarction Rats - DocWire News - November 26th, 2019
- Prevalence of Bacterial and Fungal Infections the Oral Cavity in Patients with Acute Myocardial Infarction Treated with Primary Coronary Intervention... - November 26th, 2019
- BETonMACE: Negative Trial, but 'Cautious Optimism' on Apabetalone - Medscape - November 26th, 2019
- OTITOPIC New Clinical Trial Results Continue to Demonstrate Inhibition of Platelet Aggregation in Two Minutes With Dry Powder Inhalation of Aspirin... - November 26th, 2019
- Peas and beans: Can they improve heart health? - Medical News Today - November 26th, 2019
- Favorable outcomes with TCAR versus carotid endarterectomy in patients with carotid artery disease - Vascular News - November 26th, 2019